Login
$MQ
$17.99 -$0.24 (1.32%) Live

Company Executives

Officer Age In this role 2025 pay Source
Michael (Mike) Milotich Also a director
Chief Executive Officer
49 Not stated $11,049,523
Patti Kangwangkij
Chief Financial Officer
42 Since 2026
this year
Not reported
Todd Pollak
Chief Revenue Officer
51 Since 2023
3 years
$5,083,477
Eugenia Gibbons
Chief Product Officer
Title from the Form 4 dated Sep 15, 2026
Not stated Not stated Not reported
Lukasz Strozek
Chief Technology Officer
Title from the Form 4 dated Jun 30, 2026
Not stated Not stated Not reported
Patti Kangwankij
principal accounting officer
Title from the Form 8-K dated Aug 13, 2026
Not stated Not stated Not reported
Crystal Sumner
See Remarks
Title from the Form 4 dated Oct 15, 2026
42 Not stated $5,317,000

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 21, 2026 · updated by the 8-K of Aug 4, 2026

Directors
9
serving now
Independent
7 of 7
stated in the proxy; 2 not stated
Average tenure
4.2 years
from year joined
CEO also chairs the board
No
Jud Linville
Director Age On board Independent Committees Other public boards 2025 pay Source
Jud Linville
68 2020
6 years
Independent
Compensation
Alkami Technology, Inc. (NASDAQ: ALKT) (since 2026) Not stated
Mike Milotich
49 2025
1 year
Not stated None stated None stated Paid as CEO
Martha Cummings
65 2021
5 years
Independent
Nomination and Governance · Chair
None stated Not stated
Alpesh Chokshi
62 2024
2 years
Independent
Compensation
None stated Not stated
Elaine Paul
58 2025
1 year
Independent
Audit
Sabre (NASDAQ: SABR) (since 2024) Not stated
Kiran Prasad
49 2022
4 years
Independent
Compensation
None stated Not stated
Jason Gardner
56 2010
16 years
Not stated None stated None stated $300,000
R. Mark Graf
61 2024
2 years
Independent
Audit · Chair
Harmony Biosciences Holdings (NASDAQ: HRMY) (since 2020) Not stated
Wendy Thomas
55 2025
1 year
Independent
Audit
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 21, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support